Literature DB >> 29513890

Massive hemoptysis successfully treated with extracorporeal membrane oxygenation and endobronchial thrombolysis.

Antônio Aurélio de Paiva Fagundes Júnior1,2, Renato Bueno Chaves2, Amanda Robassini Dos Santos2, Humberto Alves de Oliveira3, Marcello Henrique Paschoal2.   

Abstract

Extracorporeal membrane oxygenation has been used to treat refractory hypoxemia in numerous clinical scenarios. The fundamental principles for the management of massive hemoptysis patients include protecting the airway and healthy lung, locating the source of bleeding and controlling the hemorrhage. We report the case of a patient with acute respiratory failure associated with massive hemoptysis secondary to lung laceration during cardiac surgery. The use of extracorporeal membrane oxygenation allowed patient survival. However, due to the great difficulty in managing pulmonary clots after hemoptysis, it was necessary to use an unusual therapy involving endobronchial infusion of a thrombolytic agent as described in rare cases in the literature.

Year:  2018        PMID: 29513890     DOI: 10.5935/0103-507X.20180002

Source DB:  PubMed          Journal:  Rev Bras Ter Intensiva        ISSN: 0103-507X


  10 in total

1.  Extracorporeal membrane oxygenation with plasma exchange in a patient with alveolar haemorrhage secondary to Wegener's granulomatosis.

Authors:  S L Barnes; M Naughton; J Douglass; D Murphy
Journal:  Intern Med J       Date:  2012-03       Impact factor: 2.048

2.  Massive haemoptysis on veno-arterial extracorporeal membrane oxygenation.

Authors:  Meredith Harrison; Scott Cowan; Nicholas Cavarocchi; Hitoshi Hirose
Journal:  Eur J Cardiothorac Surg       Date:  2012-03-30       Impact factor: 4.191

3.  Life-threatening hemoptysis due to left inferior phrenic artery to pulmonary artery fistula rescued by extracorporeal membrane oxygenation therapy.

Authors:  Shao-Jung Hsu; Yung-Hung Luo; Yu-Chin Lee; Kuang-Yao Yang
Journal:  Interact Cardiovasc Thorac Surg       Date:  2010-11-19

4.  Extracorporeal membrane oxygenation for the management of respiratory failure caused by diffuse alveolar hemorrhage.

Authors:  Zhen Guo; Xin Li; Li-Yan Jiang; Ling-Feng Xu
Journal:  J Extra Corpor Technol       Date:  2009-03

5.  Endobronchial streptokinase to dissolve a right mainstem clot.

Authors:  D B Thomson
Journal:  Chest       Date:  1986-06       Impact factor: 9.410

6.  Endobronchial urokinase for dissolution of massive clot following transbronchial biopsy.

Authors:  W Botnick; H Brown
Journal:  Chest       Date:  1994-03       Impact factor: 9.410

7.  Endobronchial streptokinase for bronchial obstruction by blood clots.

Authors:  R P Cole; G J Grossman
Journal:  N Engl J Med       Date:  1983-04-14       Impact factor: 91.245

8.  Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial.

Authors:  Giles J Peek; Miranda Mugford; Ravindranath Tiruvoipati; Andrew Wilson; Elizabeth Allen; Mariamma M Thalanany; Clare L Hibbert; Ann Truesdale; Felicity Clemens; Nicola Cooper; Richard K Firmin; Diana Elbourne
Journal:  Lancet       Date:  2009-09-15       Impact factor: 79.321

9.  ECMO Rescue Therapy in Diffuse Alveolar Haemorrhage: A Case Report with Review of Literature.

Authors:  Gautam Rawal; Raj Kumar; Sankalp Yadav
Journal:  J Clin Diagn Res       Date:  2016-06-01

10.  Extracorporeal membrane oxygenation in diffuse alveolar hemorrhage secondary to systemic lupus erythematosus.

Authors:  Christine Pacheco Claudio; Emmanuel Charbonney; Madeleine Durand; Christophe Kolan; Mikhael Laskine
Journal:  J Clin Med Res       Date:  2014-02-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.